Jha, Manish K.
Malchow, Ashley L.
Grannemann, Bruce D. http://orcid.org/0000-0001-6888-7590
Rush, A. John
Trivedi, Madhukar H. http://orcid.org/0000-0002-2983-1110
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (N01MH90003)
Article History
Received: 13 February 2018
Revised: 3 July 2018
Accepted: 26 July 2018
First Online: 15 August 2018
Competing interests
: Ms. Malchow and Mr. Grannemann have no potential conflicts of interest. Dr. Jha has received contract research support from Acadia Pharmaceuticals and Janssen. Dr. Rush has received consulting fees from Akili, Brain Resource Inc., Compass Inc., Curbstone Consultant LLC, Emmes Corp, Johnson and Johnson (Jannsen), Liva-Nova, Mind Linc., Sunovion, Taj Medical; speaking fees from Liva-Nova; and royalties from Guilford Press and the University of Texas Southwestern Medical Center, Dallas, TX. (for the Inventory of Depressive Symptoms and its derivatives). He is also named co-inventor on two patents: U.S. Patent No. 7,795,033: Methods to Predict the Outcome of Treatment with Antidepressant Medication, Inventors: McMahon FJ, Laje G, Manji H, Rush AJ, Paddock S, Wilson AS and U.S. Patent No. 7,906,283: Methods to Identify Patients at Risk of Developing Adverse Events During Treatment with Antidepressant Medication, Inventors: McMahon FJ, Laje G, Manji H, Rush AJ, Paddock S. Dr. Trivedi, is or has been an advisor/consultant and received fee from: Alkermes, AstraZeneca, Cerecor, Eli Lilly & Company, Lundbeck, Naurex, Otsuka Pharmaceuticals, Pamlab, Pfizer Inc., and Takeda. In addition, he has received grants/research support from National Institute of Mental Health and National Institute on Drug Abuse.